During neural development in animals, GABAergic and glycinergic neurons are first excitatory, and then become inhibitory in the mature state. This developmental shift is mainly due to strong expression of the cation‐chloride KCC2 and down‐regulation of co‐transporters NKCC1 during maturation. The down‐regulation of co‐transporter KCC2 after spinal cord transection in animals leads to the depolarising (excitatory) action of GABA and glycine and thus results in a reduction of inhibitory synaptic efficiency. Furosemide, a loop diuretic, has been shown to selectively and reversibly block inhibitory postsynaptic potentials (IPSPs) without affecting excitatory postsynaptic potentials (EPSPs) in animal spinal neurons. Moreover, this diuretic has been also demonstrated to block the cation‐chloride co‐transporters. Here, we used furosemide to demonstrate changes in spinal inhibitory networks in healthy human subjects. Non‐invasive electrophysiological techniques were used to assess presynaptic inhibition, postsynaptic inhibition and the efficacy of synaptic transmission between muscle afferent terminals and soleus motoneurons in the spinal cord. Orally‐administered furosemide, at doses commonly used in the clinic (40 mg), significantly reduced spinal inhibitory interneuronal activity for at least 70 min from intake compared to control experiments in the same subjects while no changes were observed in the efficacy of synaptic transmission between muscle afferent terminals and soleus motoneurons. The reduction of inhibition was dose‐dependent. Our results provide indirect evidence that reversible changes in the cation‐chloride transport system induce modulations of inhibitory neuronal activity at spinal cord level in humans. This article is protected by copyright. All rights reserved